Company Filing History:
1 out of 1,509 
Years Active: 2024-2025
Title: The Innovations of Andreas Lothar Severino Maderna
Introduction
Andreas Lothar Severino Maderna is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative conjugates for medical applications. With a total of 2 patents, Maderna's work focuses on advancing treatments for diseases such as cancer.
Latest Patents
Maderna's latest patents include "Conjugates comprising cleavable beta-glucuronide-containing linkers" and "Conjugates comprising cleavable linkers." The first patent relates to conjugates that include a specific linker formula and pharmaceutically acceptable salts. This invention is aimed at providing effective treatments for cancer and includes intermediates useful for synthesizing these conjugates. The second patent also focuses on conjugates with a different linker formula, similarly targeting cancer treatment and the synthesis of these compounds.
Career Highlights
Maderna is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca emphasizes the importance of innovative drug development and the potential for new therapies to improve patient outcomes. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Maderna has collaborated with notable colleagues, including Akbar Husain Khan and Maximillian Taro William Lee. These collaborations highlight the importance of teamwork in the field of pharmaceutical research and development.
Conclusion
Andreas Lothar Severino Maderna's innovative work in the pharmaceutical industry exemplifies the impact of dedicated inventors on medical advancements. His patents and collaborations contribute significantly to the ongoing fight against diseases like cancer.